eagleus.com is a domain
that was created on 2007-09-12,making it 17 years ago.
It has several subdomains, such as investor.eagleus.com , among others.
Description:Eagle Pharmaceuticals is a specialty pharmaceutical company realizing the untapped potential of life-saving medicines. See what we’re doing to bring brilliant science to...
Discover eagleus.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 97.029 KB |
Page Load Time: 0.729364 Seconds |
Website IP Address: 192.124.249.55 |
Wingstop Restaurants Inc. Investor Relations – NASDAQ: WING |
Investor Relations & IR Management Solutions | Nasdaq |
Investor Relations - Nasdaq, Inc. |
Eagle Pharmaceuticals Investor Center | |
Investor Relations & IR Management Solutions | Nasdaq |
Investor Relations & IR Management Solutions | Nasdaq |
Home Page - Llama Firearms by Eagle Imports Inc - Eagle |
Nasdaq Data Link Documentation |
Nasdaq Entrepreneurial Center | A global community of entrepreneurs |
Lifeline Pharmaceuticals, LLC’s Login Page | Lifeline Pharmaceuticals, LLC |
Mama's Creations, Inc. (NASDAQ: |
Eagle Pharmaceuticals, Inc. | Success is Where We Start | (NASDAQ: EGRX) https://www.eagleus.com/ |
Investors | Eagle Pharmaceuticals, Inc. https://investor.eagleus.com/ |
Products | Eagle Pharmaceuticals Inc. (EGRX) https://www.eagleus.com/products/ |
About Us | Eagle Pharmaceuticals Inc. (EGRX) https://www.eagleus.com/about/ |
Eagle Pharmaceuticals Provides Business Update and Guidance for 2023 https://investor.eagleus.com/news-releases/news-release-details/eagle-pharmaceuticals-provides-business-update-and-guidance-2023 |
News Details - Eagle Pharmaceuticals, Inc. https://investor.eagleus.com/news-releases/news-release-details/eagle-pharmaceuticals-reports-fourth-quarter-and-full-year-2022 |
Pipeline | Eagle Pharmaceuticals Inc. (EGRX) https://www.eagleus.com/pipeline/ |
Eagle Pharmaceuticals Commences Pivotal Study for Fulvestrant | Eagle ... https://investor.eagleus.com/news-releases/news-release-details/eagle-pharmaceuticals-commences-pivotal-study-fulvestrant |
Eagle Pharmaceuticals Provides 2022 Business Update and Announces ... https://investor.eagleus.com/news-releases/news-release-details/eagle-pharmaceuticals-provides-2022-business-update-and |
Eagle Pharmaceuticals, Inc. | The Eagle Team https://www.eagleus.com/leadership/ |
A eagleus.com. 10800 IN A 192.124.249.55 |
MX eagleus.com. 1800 IN MX 10 eagleus-com.mail.protection.outlook.com. |
NS eagleus.com. 3600 IN NS ns19.domaincontrol.com. |
TXT eagleus.com. 1800 IN TXT v=spf1 ip4:108.53.199.5 include:spf.protection.outlook.com include:spf.mtasv.net include:o1.7nn.fshared.sendgrid.net include:o1682455182.outbound-mail.sendgrid.net include:mailgun.org -all |
SOA eagleus.com. 3600 IN SOA ns19.domaincontrol.com. dns.jomax.net. 2023121900 28800 7200 604800 600 |
Server: Sucuri/Cloudproxy |
Date: Tue, 14 May 2024 05:48:52 GMT |
Content-Type: text/html; charset=UTF-8 |
Content-Length: 88659 |
Connection: keep-alive |
X-Sucuri-ID: 11005 |
X-XSS-Protection: 1; mode=block |
X-Frame-Options: SAMEORIGIN |
X-Content-Type-Options: nosniff |
Content-Security-Policy: upgrade-insecure-requests; |
Vary: X-Forwarded-Proto,Accept-Encoding |
Last-Modified: Tue, 14 May 2024 05:15:58 GMT |
ETag: "15a53-6186318e737d6" |
Referrer-Policy: no-referrer-when-downgrade |
Pragma: public |
Cache-Control: max-age=3600, public |
X-Sucuri-Cache: EXPIRED |
Accept-Ranges: bytes |
charset="utf-8"/ |
content="width=device-width, initial-scale=1.0, minimum-scale=1.0, maximum-scale=1.0, user-scalable=0" name="viewport"/ |
content="IE=edge,chrome=1" http-equiv="X-UA-Compatible"/ |
content="telephone=no" name="format-detection"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots" |
content="Eagle Pharmaceuticals is a specialty pharmaceutical company realizing the untapped potential of life-saving medicines. See what we’re doing to bring brilliant science to life." name="description"/ |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Eagle Pharmaceuticals, Inc. | Success is Where We Start | (NASDAQ: EGRX)" property="og:title"/ |
content="Eagle Pharmaceuticals is a specialty pharmaceutical company realizing the untapped potential of life-saving medicines. See what we’re doing to bring brilliant science to life." property="og:description"/ |
content="https://www.eagleus.com/" property="og:url"/ |
content="Eagle Pharmaceuticals" property="og:site_name"/ |
content="2023-10-24T15:18:46+00:00" property="article:modified_time"/ |
content="summary_large_image" name="twitter:card"/ |
content="Powered by LayerSlider 6.5.1 - Multi-Purpose, Responsive, Parallax, Mobile-Friendly Slider Plugin for WordPress." name="generator"/ |
content="WordPress 6.5.3" name="generator"/ |
content="MasterSlider 3.1.3 - Responsive Touch Image Slider" name="generator"/ |
content="Eagle_Admin" itemprop="author"/ |
content="April 14, 2020" itemprop="datePublished"/ |
content="October 24, 2023" itemprop="dateModified"/ |
content="Eagle Pharmaceuticals" itemprop="publisher"/ |
content="Powered by Visual Composer - drag and drop page builder for WordPress." name="generator"/ |
content="Powered by Slider Revolution 5.4.5.1 - responsive, Mobile-Friendly Slider Plugin for WordPress with comfortable drag and drop interface." name="generator"/ |
content="https://www.eagleus.com/wp-content/uploads/2018/02/cropped-eagle_favicon_blue_512x512-270x270.png" name="msapplication-TileImage"/ |
content="Jupiter Child 2.1.0" name="generator"/ |
content="GHQ8FqeuHu1ti2CM93hNdoFJp2-n3L09qkMkZ7w_vjk" name="google-site-verification"/ |
Ip Country: United States |
City Name: Menifee |
Latitude: 33.6637 |
Longitude: -117.1743 |
Our Portfolio has Expanded: Learn more about BARHEMSYS ® (amisulpride) injection and BYFAVO ® (remimazolam) for injection ABOUTVISION AND VALUES MEET THE TEAM PRODUCTS PIPELINE Impact INVESTORS CAREERS CONTACT US ABOUTVISION AND VALUES MEET THE TEAM PRODUCTS PIPELINE Impact INVESTORS CAREERS CONTACT US NEWS FROM EAGLE FIND OUT WHAT’S NEW AT EAGLE TOP STORIES Eagle Granted Patent for PEMFEXY ® Eagle Granted Unique J-Code and Pass-Through Status for BARHEMSYS ® Eagle Awarded First Prize for Poster Read the latest from Eagle Pharmaceuticals PRESS RELEASESPURSUING SCIENCE TO HELP PATIENTS We discover, develop, and market medicines that matter to patients, healthcare providers, and health systems. We put science to work to serve a greater cause, helping patients and improving healthcare in the process. SEE WHY WE DO IT OUR PRODUCTS OUR COLLECTIVE COMMITMENT Everything great starts with commitment. Our commitment to those whose lives are enriched by our products is unmatched. It fuels our ingenuity and passion for making a difference to patients, healthcare providers, and health systems. EXPLORE OUR PORTFOLIO PIPELINE HELPING MEDICINES DO MORE A first-in-class new chemical entity (NCE) pipeline with promising product candidates that have the potential to help millions of patients across oncology and critical care. SEE WHAT’S IN THE WORKS INVESTORS THE SKY IS THE LIMIT Our strategic focus is to provide value for patients, healthcare providers, and health systems. We know that by doing so, we create value for all our stakeholders. The bottom line is that we believe our growing portfolio has the power to benefit everyone. HOW WE’RE CREATING VALUE PRIVACY POLICY TERMS OF USE SITEMAP CONTACT US COOKIE SETTINGS DO NOT SELL OR SHARE MY PERSONAL INFORMATION © 2023 Eagle Pharmaceuticals, Inc. All rights reserved. Woodcliff Lake, NJ 07677 We have updated our Privacy and Cookie Policies. We have updated our Privacy and Cookie Policies to provide additional information, including new information for California residents and updated information and choices in connection with how we and our partners collect information via cookies. Please read our updated privacy and cookie policies here . You can adjust cookie settings for the website here . By clicking Accept, you agree to our updated privacy and cookie policies. ACCEPT Manage consent Close Cookie Settings We use cookies to analyze website usage and assist our marketing efforts. Your cookie preference will be stored on your browser, and is categorized as a "Necessary" cookie. Third-party cookies we use to collect website analytics will be stored in your browser only with your consent. You also have the option to opt-out of these cookies using the tool below. Privacy Policy Cookie Policy Notice to California Residents Necessary Necessary Always Enabled Necessary cookies store cookie preferences made here in the cookie settings tools. Cookie Duration Description Cookie Preference 11 months This cookie is used to store cookie preferences made here in the cookie settings tool. Analytics Analytics Analytical cookies are used to understand how visitors interact with the website. These cookies provide information about the number of visitors, bounce rate, traffic source, etc. Cookie Duration Description Google Analytics 11 months A unique identifier given to each browser to track user interactions with the website. SAVE &...
Domain Name: EAGLEUS.COM Registry Domain ID: 1212812099_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2023-09-13T16:45:55Z Creation Date: 2007-09-12T16:38:38Z Registry Expiry Date: 2024-09-12T16:38:38Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS19.DOMAINCONTROL.COM Name Server: NS20.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T19:21:57Z <<<